190 related articles for article (PubMed ID: 29605146)
1. Principles and applications of pharmacometrics in drug evaluation in children.
Leroux S; Elie V; Zhao W; Magreault S; Jacqz-Aigrain E
Therapie; 2018 Apr; 73(2):165-170. PubMed ID: 29605146
[TBL] [Abstract][Full Text] [Related]
2. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.
Samardzic J; Allegaert K; Wilbaux M; Pfister M; van den Anker JN
Expert Opin Drug Metab Toxicol; 2016; 12(4):367-75. PubMed ID: 26817821
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of drug evaluation in children by population methods and modelling.
Tod M; Jullien V; Pons G
Clin Pharmacokinet; 2008; 47(4):231-43. PubMed ID: 18336053
[TBL] [Abstract][Full Text] [Related]
5. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.
Rodvold KA; Everett JA; Pryka RD; Kraus DM
Clin Pharmacokinet; 1997 Jul; 33(1):32-51. PubMed ID: 9250422
[TBL] [Abstract][Full Text] [Related]
7. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
Prokopczyk J; Piekarczyk A; Kaminska E
Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
[TBL] [Abstract][Full Text] [Related]
8. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
[TBL] [Abstract][Full Text] [Related]
9. How to use vancomycin optimally in neonates: remaining questions.
Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
[TBL] [Abstract][Full Text] [Related]
10. Expanding clinical applications of population pharmacodynamic modelling.
Minto C; Schnider T
Br J Clin Pharmacol; 1998 Oct; 46(4):321-33. PubMed ID: 9803979
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
[TBL] [Abstract][Full Text] [Related]
12. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
13. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
[TBL] [Abstract][Full Text] [Related]
14. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM
Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139
[TBL] [Abstract][Full Text] [Related]
15. Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians.
Meesters K; Balbas-Martinez V; Allegaert K; Downes KJ; Michelet R
Paediatr Drugs; 2024 Jul; 26(4):365-379. PubMed ID: 38755515
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in neonates.
Patrick CH
Neonatal Netw; 1995 Mar; 14(2):21-6. PubMed ID: 7746237
[TBL] [Abstract][Full Text] [Related]
17. Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life.
van Donge T; Evers K; Koch G; van den Anker J; Pfister M
Handb Exp Pharmacol; 2020; 261():325-337. PubMed ID: 30968215
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
19. Principles of therapeutic drug monitoring.
Zhao W; Jacqz-Aigrain E
Handb Exp Pharmacol; 2011; 205():77-90. PubMed ID: 21882106
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review.
Leroux S; Mechinaud-Heloury F; Jacqz-Aigrain E
Front Pharmacol; 2021; 12():635345. PubMed ID: 33867986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
